Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.5M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
8.13M
-
Shares change
-
+522K
-
Total reported value, excl. options
-
$119M
-
Value change
-
+$7.35M
-
Put/Call ratio
-
1.36
-
Number of buys
-
33
-
Number of sells
-
-39
-
Price
-
$14.61
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q3 2023
94 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q3 2023.
AVITA Medical, Inc. - Common Stock (RCEL) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.13M shares
of 26.5M outstanding shares and own 30.71% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.72M shares), VANGUARD GROUP INC (1.36M shares), GEODE CAPITAL MANAGEMENT, LLC (499K shares), Driehaus Capital Management LLC (496K shares), PURA VIDA INVESTMENTS, LLC (481K shares), STATE STREET CORP (469K shares), Russell Investments Group, Ltd. (368K shares), EAM Investors, LLC (249K shares), NORTHERN TRUST CORP (219K shares), and Calamos Advisors LLC (211K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.